Mixed myeloid chimerism and hemolytic markers after nonmyeloablative HCT for sickle cell disease
Authors:
- Zaina InamZIZaina Inam
- Francis J. PiercieyFPFrancis J. Pierciey
- Matthew HsiehMHMatthew Hsieh
- Alexis LeonardALAlexis Leonard
- Selami DemirciSDSelami Demirci
- John TisdaleJTJohn Tisdale
Open Access
- 17 August 2026
- journal article
- Published by Elsevier in Blood Red Cells & Iron
- Vol. 2 (4)
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 32 references indexed in Scilit:
- Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research AllianceTransplantation and Cellular Therapy, 2022
- Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 studyAmerican Journal of Hematology, 2022
- Determinants of severity in sickle cell diseaseBlood Reviews, 2022
- Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyTransplantation and Cellular Therapy, 2021
- Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemiaBlood Reviews, 2020
- Relationship between Mixed Donor–Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell DiseaseTransplantation and Cellular Therapy, 2017
- Early Reticulocytosis and Anemia Are Associated with Abnormal and Conditional Transcranial Doppler Velocities in Children with Sickle Cell AnemiaThe Journal of Pediatrics, 2016
- Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell PhenotypeJAMA, 2014
- Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the CooperativeStudy of SickleCellDiseaseAmerican Journal of Hematology, 2014
- Human CD34+ and CD34+CD38− hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cellsExperimental Hematology, 2004